Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants

Yukihide Momozawa,Rumi Sasai,Yoshiaki Usui,Kouya Shiraishi,Yusuke Iwasaki,Yukari Taniyama,Michael T. Parsons,Keijiro Mizukami,Yuya Sekine,Makoto Hirata,Yoichiro Kamatani,Mikiko Endo,Chihiro Inai,Sadaaki Takata,Hidemi Ito,Takashi Kohno,Koichi Matsuda,Seigo Nakamura,Kokichi Sugano,Teruhiko Yoshida,Hidewaki Nakagawa,Keitaro Matsuo,Yoshinori Murakami,Amanda B. Spurdle,Michiaki Kubo
DOI: https://doi.org/10.1001/jamaoncol.2022.0476
IF: 33.006
2022-04-14
JAMA Oncology
Abstract:This case-control study examines the association of BRCA1 and BRCA2 pathogenic variants with additional cancer types and their clinical characteristics in 100 914 Japanese individuals across 14 cancer types.
medicine, general & internal
What problem does this paper attempt to address?